The broad-spectrum caspase inhibitor Boc-Asp-CMK induces cell death in human leukaemia cells by Frydrych, Ivo et al.
Toxicology in Vitro 22 (2008) 1356–1360Contents lists available at ScienceDirect
Toxicology in Vitro
journal homepage: www.elsevier .com/ locate/ toxinvi tThe broad-spectrum caspase inhibitor Boc-Asp-CMK induces cell death
in human leukaemia cells
Ivo Frydrych a,1, Petr Mlejnek a,1,*, Petr Dolezel a, Vassilis Zoumpourlis b, Petra Krumpochova a
aDepartment of Biology, Faculty of Medicine, Palacky University, Hnevotinska 3, Olomouc 77515, Czech Republic
bUnit of Biomedical Applications, Institute of Biological Research and Biotechnology, National Hellenic Research Foundation, Athens, Greecea r t i c l e i n f o
Article history:
Received 30 October 2007
Accepted 28 February 2008
Available online 4 March 2008
Keywords:
Caspase-3 processing
Cell respiration
Apoptosis
Necrosis
U937 cells0887-2333/$ - see front matter  2008 Elsevier Ltd. A
doi:10.1016/j.tiv.2008.02.017
* Corresponding author. Tel.: +420 585632158; fax
E-mail address: mlejnek_petr@volny.cz (P. Mlejne
1 Both authors have equally contributed to this wora b s t r a c t
Synthetic caspase inhibitors and particularly broad-spectrum caspase inhibitors can prevent cells from
death or at least slow down cell death process and abrogate some apoptotic hallmarks [Kitanaka, C.,
Kuchino, Y., 1999. Caspase-independent programmed cell death with necrotic morphology. Cell Death
and Differentiation 6, 508–515]. However, not all synthetic caspase inhibitors diminish cell death. We
have found that the broad-spectrum caspase inhibitor Boc-Asp-CMK induced cell death at micromolar
concentrations in human leukaemia cells. Interestingly, low concentrations of Boc-Asp-CMK induced cell
death with apoptotic hallmarks. Increasing concentrations of Boc-Asp-CMK led to necrotic cell death. The
switch between apoptosis and necrosis seemed to depend upon the degree of inhibition of executioner
caspases, including caspase-3/7 with Boc-Asp-CMK. Interestingly, caspase-3 processing was not inhibited
even for the highest concentration of Boc-Asp-CMK used. We assume, that toxic properties of Boc-Asp-
CMK can be attributed to the chloromethylketone residuum in its molecule, as its analogue Boc-Asp-
FMK with ﬂuoromethylketone residuum was more than 13 times less toxic. Our results further indicated
that toxicity of Boc-Asp-CMK might arise from its interference with mitochondrial metabolism.
 2008 Elsevier Ltd. All rights reserved.1. Introduction
Caspases are a family of cysteine proteases that play a central
role in apoptosis (Cohen, 1997). The involvement of caspases in
apoptosis was ﬁrst observed by the Horvitz’s research group,
who studied the programmed cell death in the nematode worm
Caenorhabditis elegans (Ellis and Horvitz, 1986; Yuan et al., 1993).
Since then, the conserved mechanism of apoptosis has been iden-
tiﬁed in a number of species, including humans.
The ﬁnding that caspases are indispensable for the apoptotic
cell death programme has prompted the search for caspase inhib-
itors, which might offer a tool for modulation of this process. Syn-
thetic peptide inhibitors that have been developed act by binding
to the active site of caspases either in a reversible or irreversible
manner. Inhibitor design includes a peptide recognition sequence
attached to a functional group such as an aldehyde (CHO), chloro-
methylketone (CMK), or ﬂuoromethylketone (FMK). Caspase inhib-
itors with CMK or FMK group are irreversible while those with CHO
group are reversible. In general, protease inhibitors with FMK
group are less reactive than those with CMK group and thereforell rights reserved.
: +420 585632966.
k).
k.are considered as more speciﬁc for the enzyme site being inhibited
(Otto and Schirmeister, 1997).
Synthetic peptide inhibitors that are commercially available
either exhibit some selectivity for the different caspases or act
without apparent selectivity as broad-spectrum caspase inhibitors.
First reports suggested that caspase inhibitors and particularly
broad-spectrum caspase inhibitors could prevent cells from death.
Further experiments, however, showed that this conclusion was
oversimpliﬁed. At present time it is evident that caspase inhibitors
can slow down cell death process and abrogate some apoptotic
hallmarks but in fact they fail to prevent cells from death in most
experimental systems (Green and Kroemer, 1998).
In this paper we demonstrate that the broad-spectrum caspase
inhibitor Boc-Asp-CMK is toxic and induces cell death in micromo-
lar concentrations. Its toxicity is probably due to CMK group in its
molecule that interferes with mitochondrial functions.2. Materials and methods
2.1. Cell culture
U937 cells were cultured in RPMI-1640 medium supplemented
with 10% calf foetal serum and antibiotics in 5% CO2 atmosphere
at 37 C. Cells were maintained at density from 1  105 to
6  105 cells per ml. The cell density was determined using
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Fig. 1. Effect of Boc-D-CMK and Boc-D-FMK on proliferation of U937 cells. Cells
were treated with Boc-D-CMK (circles) or Boc-D-FMK (triangles), as indicated. After
24 h incubation cells were subjected to the MTT assay. Untreated cells were taken
as a control. The experimental points represent mean values from three replicate
experiments with standard deviations.
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tained from ECACC.
2.2. Chemicals and cell treatment
Broad-spectrum caspase inhibitor, Boc-D-(OBzl)-CMK (Bachem,
Bubendorf, Switzerland) and Boc-D-(OMe)-FMK (MP Biomedicals,
Ohio, USA) were dissolved in DMSO. The ﬁnal concentration of
DMSO in culture medium was approximately 0.1%. 3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was ob-
tained from Duchefa (Haarlem, Netherlands). Propidium iodide
and Hoechst 33342 were obtained from Fluka (Buchs, Switzerland).
2.3. Determination of cell survival and proliferation
The MTT assay was used for estimation of cell viability and
growth as originally described by Mosmann (1983). Cells were
incubated in the presence of 0.5 mg MTT/ml (ﬁnal concentration)
for 1 h at 37 C, then pelleted by centrifugation and extracted by
isopropanol acidiﬁed with 0.01 M HCl. Absorbance was read at
570 nm in extracts clariﬁed by centrifugation. The amount of for-
mazane produced is proportional to the number of live and meta-
bolically active cells.
2.4. Morphological analysis of apoptosis
Cells were ﬁxed and stained with Hoechst 33342 as described
previously (Mlejnek and Kuglik, 2000). The nuclear morphology
was examined using a ﬂuorescence microscope.
2.5. Measurement of caspase enzymatic activity in cell extracts
Caspase-3/7 enzymatic activities were determined using ﬂuo-
rescent substrate, as described previously (Mlejnek, 2001).
2.6. Immunoblot analysis (Western blot analysis)
Pelleted cells were extracted by lysis buffer (50 mM Tris/HCl
buffer pH 8.1 containing 1% NP-40, 150 mM NaCl, 50 mM NaF,
5 mM EDTA and 5 mM sodium pyrophosphate, supplemented with
protease (Roche) and phosphatase (Sigma) inhibitor cocktails). Cell
extracts were mixed with 4 Laemmli buffer, and the samples
were heated to 96 C for 5 min. Samples equivalent to 30 lg pro-
tein were analysed by Western blot using a polyclonal anti-cas-
pase-3 antibody (1:1000) recognizing both pro- and active forms,
polyclonal anti-Akt antibody (1:1000; Cell Signalling Technology,
Beverly, MA) or monoclonal anti-b-actin (1:2000; Sigma). The sig-
nal was detected using a horseradish peroxidase-conjugated sec-
ondary antibody (1:2000; Dako, Glostrup, Denmark). Products
were visualized using an enhanced chemiluminiscence (ECL;
Amersham, Little Chalfont, UK).
2.7. Oxygen consumption
Oxygen consumption (the respiratory activity) of intact cells
was measured using a Clark-type oxygen electrode (Thermo Or-
ion, Thermo Scientiﬁc, USA). A sample chamber with a stir mag-
net was ﬁlled with 1.9 ml of fresh growth medium and allowed
to equilibrate at 37 C for 5 min. Measurement started by addi-
tion of 8.0  106 cells in volume of 0.1 ml and oxygen consump-
tion was monitored for 10 min; subsequently, 20 ll of KCN (ﬁnal
concentration, 1 mM) was added and oxygen consumption was
monitored another 10 min. The system was calibrated with
oxygen-saturated water, which contains 217 nmol of O2/ml at
sea level, at 37 C for 1 h. All oxygen consumption assays were
repeated three times.2.7. Assessment of mitochondrial transmembrane potentials
Cells were incubated for 15 min in 50 nmol TMRE (tetramethyl-
rhodamine ethyl ester perchlorate) at 37 C in growth medium.
Stained cells were immediately analysed on a Cytomics FC 500 Sys-
tem (Beckman Coulter, Fullerton, CA, USA) with argon laser excita-
tion at 488 nm and emission at 575 nm. At least 10,000 cells in
each sample were analysed. The control experiment was
performed in untreated cells and in cells treated with 50 lmol
carbamoyl cyanide m-chlorophenylhydrazone (mClCCP, an
uncoupling agent that abolishes Dwm) for 20 min at 37 C.
3. Results
U937 cells responded to the treatment with Boc-D-CMK by a
concentration dependent decrease in cell proliferation, which
could be demonstrated by standard MTT assay (Fig. 1, Table 1).
In contrast, its ﬂuoromethylketone analogue, Boc-D-FMK exhibited
only weak effect on cell proliferation (Fig. 1, Table 1). More detailed
analysis revealed that Boc-D-CMK down-regulated Akt expression,
that reﬂected not only decreased proliferation potential but also
higher susceptibility of treated cells to death (Fig. 2). Indeed, we
found that Boc-D-CMK induced cell death in U937cells. While con-
centrations up to 10 lM of Boc-D-CMK induced apoptosis, higher
concentrations induced necrotic-like cell death as judged from cell
nuclei morphology (Fig. 3). These results indicated that the de-
crease in cell proliferation induced by Boc-D-CMK was mainly
due to loss of cell viability (Fig. 1 and Fig. 3). On the other hand,
the decrease in cell proliferation induced by Boc-D-FMK (Fig. 1)
could be attributed only partly to the loss of cell viability (not
shown). To conﬁrm that cell death induced by low concentrations
of Boc-D-CMK was apoptotic, we measured enzymatic activity of
caspase-3/7. Our results clearly indicated that Boc-D-CMK could
activate caspase-3/7 at low concentrations (Fig. 4). Western blot
analysis conﬁrmed that Boc-D-CMK induced caspase-3 activation
(Fig. 5). Surprisingly, caspase-3 was activated even at concentra-
tions of Boc-D-CMK that almost fully inhibited caspase-3 activity
(Figs. 4 and 5).
Table 1
Effect of Boc-D-CMK and Boc-D-FMK on proliferation and survival of U937 cells
Inhibitor IC50 (lM)
Boc-D-CMK 6.8
Boc-D-FMK 91.1
Fig. 2. Effect of Boc-D-CMK and Boc-D-FMK on Akt expression in U937 cells. Cells
were treated with Boc-D-CMK or Boc-D-FMK, as indicated. After 24 h incubation
cells were lysed and Akt expression was determined using Western blot analysis,
see Section 2. Untreated cells were taken as a control. The pictures represent typical
results from three replicate experiments.
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Fig. 3. Effect of Boc-D-CMK on nuclear morphology in U937 cells. Cells were treated
with Boc-D-CMK for 24 h, stained with Hoechst, and nuclear morphology was
observed using ﬂuorescence microscopy, see Section 2. Apoptotic nuclei (circles),
necrotic nuclei (triangles). Untreated cells were taken as a control. At least 300 cells
were counted in one sample. The experimental points represent mean values from
three replicate experiments with standard deviations.
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Fig. 4. Effect of Boc-D-CMK on caspase-3 activation in U937 cells. Cells were treated
with Boc-D-CMK, as indicated. Caspase-3/7 (DEVDase) activity was determined in
cell lysates after 18 h incubation using Ac-DEVD-AMC as substrate. Untreated cells
were taken as a control. The experimental points represent mean values from three
replicate experiments with standard deviations.
Fig. 5. Effect of Boc-D-CMK on caspase-3 processing in U937 cells. Cells were
treated with Boc-D-CMK, as indicated. Caspase-3 processing was determined after
18 h incubation in cell lysates using western blotting. Untreated cells were taken as
a control. The picture represents typical results.
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Fig. 6. Effect of Boc-D-CMK on respiration in U937 cells. Cells were treated with
5 lM (circles), 10 lM (squares), or 20 lM (triangles) Boc-D-CMK. After indicated
period oxygen consumption was determined using a Clark electrode (see Section 2).
Untreated cells were taken as a control. The experimental points represent mean
values from three replicate experiments with standard deviations.
1358 I. Frydrych et al. / Toxicology in Vitro 22 (2008) 1356–1360We further tried to identify cellular target of Boc-D-CMK, which
could be responsible for the decrease of cell proliferation and cell
death. We found that Boc-D-CMK inhibited cell respiration and this
effect was found as early as 2–3 h after the treatment (Fig. 6). This
event seemed to be the earliest adverse effect of Boc-D-CMK. An-
other event that indicated mitochondrial failure was the collapse
of mitochondrial transmembrane potential DW, which was mea-
surable several hours later (Fig. 7).
4. Discussion
The ﬁnding that a broad-spectrum caspase inhibitor can induce
apoptosis sounds rather contradictory. However, detailed analysisof both our experimental data presented in this paper and data
from literature offers consistent explanation for this ﬁnding. Thus,
Boc-Asp-CMK is relatively weak inhibitor of caspase-3 and
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Fig. 7. Effect of Boc-D-CMK on mitochondrial transmembrane potential DW in U937
cells. Cells were treated with Boc-D-CMK, as indicated. DWwas determined 6 h after
the cell treatment as described in Section 2. Percentage of cells with low DW (dead
cells) is plotted against concentration of Boc-D-CMK. Untreated cells were taken as
a control. The experimental points represent mean values from three replicate
experiments with standard deviations.
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addition, Boc-Asp-(OBzl)-CMK in contrast to its analogue Boc-
Asp-(OMe)-FMK exhibited toxic effects at concentrations around
the same value (Figs. 1 and 3; Table 1). These ﬁndings clearly indi-
cated that Boc-Asp-(OBzl)-CMK could trigger apoptotic programme
in treated cells. Indeed, we observed that concentrations up to
10 lM could induce apoptosis with morphological (Fig. 3) and bio-
chemical (Figs. 4 and 5) hallmarks. Effects of Boc-Asp-CMK can be
compared to that found for TPCK (N-tosyl-L-phenylalaninyl-chloro-
methylketone), which was reported to induce apoptosis (Wu et al.,
1996; Drexler, 1997; Mlejnek, 2005) or at least enhance apoptosis
induced by other cytotoxic agents (King et al., 2004; Okada et al.,
2004). Moreover, TPCK similarly to Boc-Asp-CMK can act as non-
speciﬁc caspase inhibitor (Frydrych and Mlejnek, 2008).
We assume that the difference between toxic properties of Boc-
Asp-(OBzl)-CMK and Boc-Asp-(OMe)-FMK can be attributed to the
chloromethylketone functional group as it makes protease inhibi-
tor less selective and more reactive than those with ﬂuoromethylk-
etone functional group (Otto and Schirmeister, 1997). However,
there is one more difference between Boc-Asp-(OBzl)-CMK and
Boc-Asp-(OMe)-FMK. While Boc-Asp-(OBzl)-CMK is benzylester,
the Boc-Asp-(OMe)-FMK is methyl ester. This rise the possibility
that higher toxicity of Boc-Asp-(OBzl)-CMK can be attributed to
the benzyl alcohol which is released by esterases upon cell entry.
This seems to be unlikely owing to the fact that benzyl alcohol does
not exert adverse effects on U937 cells at relevant concentrations
(unpublished results).
Boc-Asp-(OBzl)-CMK at concentrations above 10 lM induced
necrotic-like cell death, at least according to morphological
changes (Fig. 3). This observation is not surprising regarding the
fact that the z-VAD-FMK, efﬁcient broad-spectrum caspase inhibi-
tor blocks apoptotic cell death and sensitizes cells to necrotic cell
death or alternatively it may induce autophagic cell death (Kita-
naka and Kuchino, 1999; Vandenabeele et al., 2006). The switch
from apoptosis to necrosis occurred at 15 lM Boc-Asp-CMK i.e., be-
fore the enzymatic activity of caspase-3/7 was fully abrogated (not
shown). However, 20 lM Boc-Asp-CMK fully inhibited caspase-3/7
activity and 95% of dying cells acquired necrotic-like morphology
(compare Figs. 3 and 4). Based on these results we can speculatethat there might be an additional mechanism that diminished
apoptosis and enhanced necrosis.
We further observed that Boc-Asp-CMK severely inhibited
cell respiration and this event could be measured as early as 2 h
after its addition to growth medium (not shown). Interestingly,
concentrations up to 10 lMof Boc-Asp-CMK caused reversible inhi-
bition (Fig. 6). Higher concentrations caused irreversible inhibition
(Fig. 6). The fast decrease of cell respiration was followed by fall of
mitochondrial transmembrane potential DW (Fig. 7). Although we
have no direct evidence that Boc-Asp-CMK caused a severe deple-
tion of ATP pool we can speculate that rapid and sustain inhibition
of cell respiration might disrupt energetic metabolism of cells that
contributes to necrosis.
Surprisingly, even highest concentration of Boc-Asp-CMK did
not inhibit caspase-3 processing (Fig. 5). This is important ﬁnding
since it was reported that broad-spectrum caspase inhibitor, z-
VAD-FMK, abrogated apoptosis by inhibiting of caspase-3 process-
ing (Cohen, 1997; MacFarlane et al., 1997). However, our results
clearly indicated that Boc-Asp-CMK inhibited caspase-3 activity
by direct inhibition rather than by inhibition of its processing
(compare Figs. 4 and 5). Boc-Asp-CMK is relatively weak broad-
spectrum inhibitor and its effects mimic those found for TPCK (Fry-
drych and Mlejnek, 2008).
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